Better Therapeutics (BTTX) News Today → Claim Your Complimentary Bitcoin Reward (From Crypto Swap Profits) (Ad) Free BTTX Stock Alerts $0.01 0.00 (0.00%) (As of 05/10/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineAnalysts Conflicted on These Healthcare Names: Springworks Therapeutics (SWTX) and Becton Dickinson (BDX)markets.businessinsider.com - May 6 at 9:27 AMBuy Rating Affirmed for Context Therapeutics Amid Promising CTIM-76 Developments and Competitive Edgemarkets.businessinsider.com - May 4 at 12:17 PMAnalysts Conflicted on These Healthcare Names: Viking Therapeutics (VKTX) and Bristol-Myers Squibb (BMY)markets.businessinsider.com - April 26 at 3:33 PMPrecision Combination Therapy Better Controls High-Risk Subtypes of B-ALL in Mouse Modelsmsn.com - April 10 at 8:51 AMBetter Therapeutics plans employee layoffs, strategic reviewuk.investing.com - March 16 at 9:45 AMDow Dips Over 100 Points; Dick's Sporting Goods Earnings Top Viewsmarkets.businessinsider.com - March 14 at 3:13 PMBetter Therapeutics Announces it will Seek Strategic Alternatives and will be Delisted from Nasdaqbusinesswire.com - March 14 at 9:38 AMmarketbeat.com - March 14 at 9:30 AMBetter Therapeutics Announces an Innovative Partnership with the American College of Lifestyle Medicine to Expand Access to AspyreRx Across 1,400 Federally Qualified Health Centersbusinesswire.com - March 5 at 9:25 AMBetter Therapeutics Announces Acceptance of Late Breaking Abstract for Its AspyreRx Pivotal Trial 180 Day Outcomes and Participation at the 17th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD)finance.yahoo.com - March 4 at 10:35 AMCAH Feb 2024 107.000 putfinance.yahoo.com - February 22 at 6:17 PMWhy Fluor Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Tuesday's Mid-Day Sessionbenzinga.com - February 20 at 1:52 PMBetter Therapeutics Gets Breakthrough Device Designation For Cognitive Behavioral Therapy Platformmarketwatch.com - February 20 at 1:52 PMBetter Therapeutics Receives FDA Breakthrough Device Designation for Digital Therapeutic Platform Targeting Advanced Liver Diseasebusinesswire.com - February 20 at 9:25 AMBuy Rating on Astria Therapeutics Supported by STAR-0215’s Promising Market Potential and Favorable Trial Resultsmarkets.businessinsider.com - February 6 at 1:49 PMBetter Therapeutics Enters Rebate Agreement with Pharmacy Benefit Managermarketwatch.com - February 6 at 1:49 PMBetter Therapeutics Signs Rebate Agreement with One of the Largest Pharmacy Benefit Managers in the US for its AspyreRx Diabetes Treatmentfinance.yahoo.com - February 6 at 1:49 PMDavid Perry Bought 8.6% More Shares In Better Therapeuticsfinance.yahoo.com - January 18 at 7:45 AMBetter Therapeutics Announces Publication of Cost-Effectiveness Analysis Demonstrating AspyreRx is More Effective and Less Costly than Standard of Care Alonefinance.yahoo.com - January 17 at 4:44 PMBiora Therapeutics Provides Outlook for 2024tmcnet.com - January 16 at 10:11 AMBetter Therapeutics Insiders Added US$6.57m Of Stock To Their Holdingsfinance.yahoo.com - January 3 at 2:37 PMBetter Therapeutics applies for FDA breakthrough designation for NASH devicemsn.com - January 2 at 1:52 PMBetter Therapeutics Announces Submission for FDA Breakthrough Device Designation for Digital Therapeutic Platform to Treat Liver Diseasefinance.yahoo.com - January 2 at 8:52 AMBetter Therapeutics files to sell 20M shares of common stock for holdersmsn.com - December 13 at 10:23 PMBetter Growth Stock: Viking Therapeutics or Iovance Biotherapeutics?msn.com - December 12 at 9:25 AMBetter Therapeutics amends debt facility, implements cost-saving measuresmsn.com - November 29 at 8:16 PMBetter Therapeutics Strengthens Financial Position Through Amendment to Debt Facility and Implementation of Cost Reductionsfinance.yahoo.com - November 28 at 12:42 PMFrost & Sullivan Honors Better Therapeutics with the 2023 Technology Innovation Leadership Awardfinance.yahoo.com - November 14 at 9:03 AMBetter Therapeutics, Inc. (NASDAQ:BTTX) Q3 2023 Earnings Call Transcriptfinance.yahoo.com - November 12 at 1:24 PMBetter Therapeutics: Q3 Earnings Insightsbenzinga.com - November 9 at 10:12 AMBetter Therapeutics to Release Third Quarter 2023 Financial Results and Provide Business Update on November 09, 2023finance.yahoo.com - November 8 at 12:44 PMBetter Therapeutics to Participate in the American College of Lifestyle Medicine’s 2023 Annual Conferencefinance.yahoo.com - October 26 at 8:51 AMBetter Therapeutics Announces Launch of AspyreRx TM to Treat Adults with Type 2 Diabetesbusinesswire.com - October 17 at 9:11 PMBetter Therapeutics Announces Launch of AspyreRxTM to Treat Adults with Type 2 Diabetesfinance.yahoo.com - October 16 at 10:07 AMBetter Therapeutics Announces New Data Highlighting Concurrent Use of AspyreRx and GLP-1 Receptor Agonists to Treat Type 2 Diabetesfinance.yahoo.com - October 11 at 10:38 AMBetter Therapeutics Announces Publication of LivVita Liver Disease Study Results in Gastro Hep Advancesfinance.yahoo.com - October 5 at 10:02 AMWhy Shares of BioXcel Therapeutics Fell This Weekmsn.com - September 28 at 7:44 PMAquestive (AQST) Up on Reaffirming Anaphylm Development Pathwaymsn.com - September 21 at 5:38 PMBetter Therapeutics Inc.thestreet.com - September 14 at 8:58 AMBetter Therapeutics Reports Second Quarter 2023 Financial Results and Provides Business Updatesfinance.yahoo.com - August 9 at 5:50 PMBetter Therapeutics to Release Second Quarter 2023 Financial Results and Provide Business Update on August 09, 2023finance.yahoo.com - August 3 at 8:39 AMBetter Therapeutics' Market Cap Drops To US$21m Leaving Insiders With Lossesfinance.yahoo.com - July 28 at 10:53 AMBetter Therapeutics Announces $6.7 Million in New Financing at an Average Price of $0.77 per Sharefinance.yahoo.com - July 25 at 10:50 AM'Digital therapeutic' for type 2 diabetes wins FDA approval, boosting its stockbizjournals.com - July 11 at 5:38 PMWhy Are Better Therapeutics Shares Gaining Today?msn.com - July 11 at 12:34 PMBetter Therapeutics Receives FDA Authorization For AspyreRx, Gains 27%markets.businessinsider.com - July 10 at 8:45 PMBetter Therapeutics, Inc.: Better Therapeutics Announces Upcoming Poster Presentation at EASL Congress 2023 in Vienna, Austriafinanznachrichten.de - June 16 at 9:26 AMBetter Therapeutics Announces Upcoming Poster Presentation at EASL Congress 2023 in Vienna, Austriafinance.yahoo.com - June 16 at 9:26 AMBetter Therapeutics, Inc. (NASDAQ:BTTX) Q1 2023 Earnings Call Transcriptinsidermonkey.com - May 17 at 5:46 PMLifeSci Capital Reaffirms Their Hold Rating on Better Therapeutics, Inc. (BTTX)markets.businessinsider.com - May 16 at 1:31 AM Get Better Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for BTTX and its competitors with MarketBeat's FREE daily newsletter. Email Address Trump’s “Tax Free” Retirement Strategy (Ad)Since 1924 — over one hundred years — the US dollar has lost nearly 18x its value. In other words, a dollar back then would buy $17.82 worth of goods in today's money. If you're planning on retiring any time soon…This poses a real problem. Protect your retirement savings from the inevitable devaluation of the dollar… BTTX Media Mentions By Week BTTX Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BTTX News Sentiment▼0.530.55▲Average Medical News Sentiment BTTX News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BTTX Articles This Week▼20▲BTTX Articles Average Week Get Better Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for BTTX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: APVO News ADTX News SXTC News NVTA News MOTS News SQZ News SMFL News CMRA News HSTO News BLPH News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:BTTX) was last updated on 5/11/2024 by MarketBeat.com Staff From Our PartnersDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe Crypto 9-5 Escape PlanCrypto 101 MediaThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldThe A.I. story nobody is telling you (Read ASAP)TradeSmithCollapse of the Petrodollar Colonial MetalsTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressHow Biden has already won 2024Porter & Company Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Better Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
